Therapeutic implications of cellular immune defects in operable cancer patients revealed by dinitrochlorobenzene skin contact sensitivity.
D000230:Adenocarcinoma / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D004137:Dinitrochlorobenzene / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D009369:Neoplasms / Q000276:immunology*; D009578:Nitrobenzenes / Q000276:immunology*; D012516:Osteosarcoma / Q000276:immunology; D012509:Sarcoma / Q000276:immunology; D012882:Skin Tests
D004137:Dinitrochlorobenzene; D009578:Nitrobenzenes